Improved ATM kinase inhibitor KU-60019 radiosensitizes glioma cells, compromises insulin, AKT and ERK prosurvival signaling, and inhibits migration and invasion

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Molecular Cancer Therapeutics

• Publication date

  2009-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/1535-7163.MCT-09-0519PMID 19808981PMCID PMC2761990
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer

  2008cited by this paper
• In Vivo Analysis of Protein Kinase B (PKB)/Akt Regulation in DNA-PKcs-null Mice Reveals a Role for PKB/Akt in DNA Damage Response and Tumorigenesis*

  2008cited by this paper
• Mouse but not human embryonic stem cells are deficient in rejoining of ionizing radiation-induced DNA double-strand breaks.

  2008cited by this paper
• PTEN has tumor-promoting properties in the setting of gain-of-function p53 mutations.

  2008cited by this paper
• Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer

  2008cited by this paper
• Malignant gliomas in adults.

  2008cited by this paper
• ATM protein kinase mediates full activation of Akt and regulates glucose transporter 4 translocation by insulin in muscle cells.

  2008cited by this paper
• PKBalpha/Akt1 acts downstream of DNA-PK in the DNA double-strand break response and promotes survival.

  2008influential reference
• Radiation-induced cell signaling: inside-out and outside-in

  2007cited by this paper
• Second messenger systems in human gliomas.

  2007cited by this paper
• Inhibition of Phosphatidylinositol-3-OH Kinase/Akt Signaling Impairs DNA Repair in Glioblastoma Cells following Ionizing Radiation*

  2007cited by this paper
• Extracellular signal-related kinase positively regulates ataxia telangiectasia mutated, homologous recombination repair, and the DNA damage response.

  2007cited by this paper
• Protein kinase C-alpha-mediated regulation of low-density lipoprotein receptor related protein and urokinase increases astrocytoma invasion.

  2007cited by this paper
• Malignant astrocytic glioma: genetics, biology, and paths to treatment.

  2007influential reference
• Ataxia Telangiectasia Mutated (ATM) Is Essential for DNA-PKcs Phosphorylations at the Thr-2609 Cluster upon DNA Double Strand Break*

  2007cited by this paper
• ATM and ATR Substrate Analysis Reveals Extensive Protein Networks Responsive to DNA Damage

  2007influential reference
• Inhibition of Akt by the alkylphospholipid perifosine does not enhance the radiosensitivity of human glioma cells

  2006cited by this paper
• Activation of p38 MAP kinase by DNA double‐strand breaks in V(D)J recombination induces a G2/M cell cycle checkpoint

  2006cited by this paper
• Cell migration and invasion assays.

  2005cited by this paper
• Deficiency in the catalytic subunit of DNA-dependent protein kinase causes down-regulation of ATM.

  2005cited by this paper
• PHLPP: a phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth.

  2005cited by this paper
• Activation of the protein kinase B pathway by the HPV-16 E7 oncoprotein occurs through a mechanism involving interaction with PP2A

  2005cited by this paper
• Full Activation of PKB/Akt in Response to Insulin or Ionizing Radiation Is Mediated through ATM*

  2005cited by this paper
• PKB/Akt mediates radiosensitization by the signaling inhibitor LY294002 in human malignant gliomas

  2005cited by this paper
• Discovery of potent chromen-4-one inhibitors of the DNA-dependent protein kinase (DNA-PK) using a small-molecule library approach.

  2005cited by this paper
• ATM and DNA-PK Function Redundantly to Phosphorylate H2AX after Exposure to Ionizing Radiation

  2004cited by this paper
• Identification and Characterization of a Novel and Specific Inhibitor of the Ataxia-Telangiectasia Mutated Kinase ATM

  2004influential reference
• Identification of a PKB/Akt Hydrophobic Motif Ser-473 Kinase as DNA-dependent Protein Kinase*♦

  2004cited by this paper
• Novel PI analogues selectively block activation of the pro-survival serine/threonine kinase Akt.

  2003cited by this paper
• ATM and related protein kinases: safeguarding genome integrity

  2003cited by this paper
• Regulation and mechanisms of mammalian double-strand break repair

  2003cited by this paper
• Regulators of serine/threonine protein phosphatases at the dawn of a clinical era?

  2002cited by this paper
• Radiosensitization of human glioma cells in vitro and in vivo with acyclovir and mutant HSV-TK75 expressed from adenovirus.

  2002cited by this paper
• Cell cycle checkpoint signaling through the ATM and ATR kinases.

  2001cited by this paper
• A truncated human xeroderma pigmentosum complementation group A protein expressed from an adenovirus sensitizes human tumor cells to ultraviolet light and cisplatin.

  2001cited by this paper
• ATM Phosphorylates Histone H2AX in Response to DNA Double-strand Breaks*

  2001cited by this paper
• ATM and ATR: networking cellular responses to DNA damage.

  2001cited by this paper
• Participation of ATM in insulin signalling through phosphorylation of eIF-4E-binding protein 1

  2000cited by this paper
• Ceramide Inhibits Protein Kinase B/Akt by Promoting Dephosphorylation of Serine 473*

  2000cited by this paper
• Regulation of protein kinase cascades by protein phosphatase 2A.

  1999cited by this paper
• Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo

  1999cited by this paper
• Substrate Specificities and Identification of Putative Substrates of ATM Kinase Family Members*

  1999cited by this paper
• The genetic defect in ataxia-telangiectasia.

  1997cited by this paper

• Oncogenic p53 induces mitotic errors in lung cancer cells by recopying DNA replication forks conferring targetable proliferation advantage.

  2026cites this paper
• Increased sensitivity of etoposide-treated breast cancer cells with an ATM inhibitor

  2026cites this paper
• Generation of Human Haematopoietic Model Cell Lines Revealed Distinct Replication Stress Tolerance Between Two Oncogenic KRAS Mutations, G12V and A146T.

  2026cites this paper
• NEK2 supports porcine embryonic development by modulating the AKT signaling pathway.

  2025cites this paper
• Manganese mediates antiviral effects by driving an ATM -TBK1 phosphorylation signaling pathway

  2025cites this paper
• Oncogenic p53 induces mitotic errors in lung cancer cells by recopying DNA replication forks conferring targetable proliferation advantage

  2025cites this paper
• Defects in the DNA Damage Response of Patient-derived Endometriosis Stromal Cells

  2025cites this paper
• Loss of CD98HC phosphorylation by ATM impairs antiporter trafficking and drives glutamate toxicity in Ataxia telangiectasia

  2025cites this paper
• Manganese mediates antiviral effects by driving an ATM -TBK1 phosphorylation signaling pathway

  2025cites this paper
• The cGAS–STING, p38 MAPK, and p53 pathways link genome instability to accelerated cellular senescence in ATM-deficient murine lung fibroblasts

  2025cites this paper
• Machine Learning-based Lactate-Related Genes Signature Predicts Clinical Outcomes and Unveils Novel Therapeutic Targets in Esophageal Squamous Cell Carcinoma.

  2025cites this paper
• The Development of ATM Inhibitors in Cancer Therapy

  2025cites this paper
• Radiosensitizers in Cancer Therapy: A Global Bibliometric Analysis

  2025cites this paper
• Improving radiotherapy in pancreatic cancer through radiosensitization strategies.

  2025cites this paper
• Cancer Vulnerabilities Through Targeting the ATR/Chk1 and ATM/Chk2 Axes in the Context of DNA Damage

  2025cites this paper
• Targeting DNA repair mechanisms in cancer therapy: the role of small molecule DNA repair inhibitors

  2025cites this paper
• ATM inhibition decreases ERK activation and is synergistic with ibrutinib in primary chronic lymphocytic leukemia cells

  2025cites this paper
• A sophisticated mechanism governs Pol ζ activity in response to replication stress

  2024cites this paper
• Chromosomal instability: a key driver in glioma pathogenesis and progression

  2024cites this paper
• Ionizing radiation effects on blood-derived extracellular vesicles: insights into miR-34a-5p-mediated cellular responses and biomarker potential

  2024cites this paper
• ATM phosphorylation of CD98HC increases antiporter membrane localization and prevents chronic toxic glutamate accumulation in Ataxia telangiectasia

  2024cites this paper
• The Effects and Mechanism of ATM Kinase Inhibitors in Toxoplasma gondii

  2024cites this paper
• The crosstalk between DNA-damage responses and innate immunity.

  2024cites this paper
• DNA damage response in brain tumors: A Society for Neuro-Oncology consensus review on mechanisms and translational efforts in neuro-oncology.

  2024cites this paper
• Small Molecular Inhibitors That Target ATM for Drug Discovery: Current Research and Potential Prospective.

  2024cites this paper
• Modeling the Acute Mucosal Toxicity of Fractionated Radiotherapy Combined with the ATM Inhibitor WSD0628

  2024cites this paper
• Preclinical Systemic Pharmacokinetics, Dose Proportionality, and Central Nervous System Distribution of the ATM Inhibitor WSD0628, a Novel Radiosensitizer for the Treatment of Brain Tumors

  2024cites this paper
• Discovery of a Novel and Potent Dual-Targeting Inhibitor of ATM and HDAC2 Through Structure-Based Virtual Screening for the Treatment of Testicular Cancer

  2024cites this paper
• ATM and 53BP1 regulate alternative end joining–mediated V(D)J recombination

  2024cites this paper
• Progress of ATM inhibitors: Opportunities and challenges.

  2024cites this paper
• Inhibition of Aberrantly Overexpressed Polo-like Kinase 4 Is a Potential Effective Treatment for DNA Damage Repair–Deficient Uterine Leiomyosarcoma

  2024cites this paper
• DNA-PKcs suppresses illegitimate chromosome rearrangements

  2024cites this paper
• Glioma Stem Cells as Promoter of Glioma Progression: A Systematic Review of Molecular Pathways and Targeted Therapies

  2024cites this paper
• The Neem Limonoid Nimbolide Modulates Key Components of the DNA Damage Response Signalling in Cellular and Animal Models of Oral Squamous Cell Carcinoma.

  2024cites this paper
• Riluzole Enhancing anti-PD-1 Efficacy by Activating cGAS/STING Signaling in Colorectal Cancer.

  2024cites this paper
• Targeting the ATM pathway in cancer: Opportunities, challenges and personalized therapeutic strategies.

  2024cites this paper
• Identification of Novel, Selective Ataxia-Telangiectasia Mutated Kinase Inhibitors with the Ability to Penetrate the Blood-Brain Barrier: The Discovery of AZD1390.

  2024cites this paper
• ATM Kinase Small Molecule Inhibitors Prevent Radiation-Induced Apoptosis of Mouse Neurons In Vivo

  2024cites this paper
• Topological stress triggers persistent DNA lesions in ribosomal DNA with ensuing formation of PML-nucleolar compartment

  2024cites this paper
• Participation of ATM, SMG1, and DDX5 in a DNA Damage-Induced Alternative Splicing Pathway

  2023influential citation
• Ataxia-Telangiectasia Mutated Is Involved in Autolysosome Formation

  2023cites this paper
• ATM-Inhibitor AZD1390 Is a Radiosensitizer for Breast Cancer CNS Metastasis

  2023cites this paper
• The Combination of ATM and Chk1 Inhibitors Induces Synthetic Lethality in Colorectal Cancer Cells

  2023cites this paper
• ATM inhibitor KU60019 synergistically sensitizes lung cancer cells to topoisomerase II poisons by multiple mechanisms

  2023cites this paper
• Inhibition of CDK12 elevates cancer cell dependence on P-TEFb by stimulation of RNA polymerase II pause release

  2023cites this paper
• Design and Optimization of Novel Benzimidazole- and Imidazo[4,5-b]pyridine-Based ATM Kinase Inhibitors with Subnanomolar Activities.

  2023cites this paper
• ATM signaling delays skin pigmentation upon UV exposure by mediating MITF function towards DNA repair mode.

  2023cites this paper
• ATR inhibition augments the efficacy of lurbinectedin in small‐cell lung cancer

  2023cites this paper
• Signalling inhibition by ponatinib disrupts productive alternative lengthening of telomeres (ALT)

  2023cites this paper
• Combined inhibition of EZH2 and ATM is synthetic lethal in BRCA1-deficient breast cancer

  2022influential citation
• Inhibition of PLK3 Attenuates Tubular Epithelial Cell Apoptosis after Renal Ischemia–Reperfusion Injury by Blocking the ATM/P53-Mediated DNA Damage Response

  2022cites this paper
• Ataxia Telangiectasia-Mutated Is Activated but Not Required for Productive Autographa californica Multiple Nucleopolyhedrovirus Infection

  2022cites this paper
• APE1 interacts with the nuclear exosome complex protein MTR4 and is involved in cisplatin‐ and 5‐fluorouracil‐induced RNA damage response

  2022cites this paper
• RYBP Sensitizes Cancer Cells to PARP Inhibitors by Regulating ATM Activity

  2022cites this paper
• DNA Damage Response in Cancer Therapy and Resistance: Challenges and Opportunities

  2022cites this paper
• High-throughput screen to identify compounds that prevent or target telomere loss in human cancer cells

  2022cites this paper
• Small Molecules and Immunotherapy Agents for Enhancing Radiotherapy in Glioblastoma

  2022cites this paper
• CDC20 regulates sensitivity to chemotherapy and radiation in glioblastoma stem cells

  2022cites this paper
• Genotoxicity-Stimulated and CYLD-Driven Malignant Transformation

  2022cites this paper
• Phospho-heavy-labeled-spiketide FAIMS stepped-CV DDA (pHASED) provides real-time phosphoproteomics data to aid in cancer drug selection

  2022influential citation
• Radiofluorination of a highly potent ATM inhibitor as a potential PET imaging agent

  2022cites this paper
• DNA damage response and repair in the development and treatment of brain tumors.

  2022cites this paper
• Integrative analysis of therapy resistance and transcriptomic profiling data in glioblastoma cells identifies sensitization vulnerabilities for combined modality radiochemotherapy

  2022cites this paper
• The epigenetic modifier HDAC2 and the checkpoint kinase ATM determine the responses of microsatellite instable colorectal cancer cells to 5-fluorouracil

  2022cites this paper
• A New Class of Selective ATM Inhibitors as Combination Partners of DNA Double-Strand Break Inducing Cancer Therapies

  2022cites this paper
• Development and Evolution of DNA-Dependent Protein Kinase Inhibitors toward Cancer Therapy

  2022cites this paper
• ATR inhibition augments the efficacy of lurbinectedin in small cell lung cancer

  2022cites this paper
• The DNA Double-Strand Break Repair in Glioma: Molecular Players and Therapeutic Strategies

  2022cites this paper
• MCT-21-0934 859..870

  2022cites this paper
• Therapeutic Targeting of DNA Damage Response in Cancer

  2022cites this paper
• Discovery of novel ataxia telangiectasia mutated (ATM) kinase modulators: Computational simulation, biological evaluation and cancer combinational chemotherapy study.

  2022cites this paper
• Development of novel urea-based ATM kinase inhibitors with subnanomolar cellular potency and high kinome selectivity.

  2022cites this paper
• Perspective on the Use of DNA Repair Inhibitors as a Tool for Imaging and Radionuclide Therapy of Glioblastoma

  2022cites this paper
• Targeting DNA repair pathway in cancer: Mechanisms and clinical application

  2021cites this paper
• New Synthetic Lethality Re-Sensitizing Platinum-Refractory Cancer Cells to Cisplatin In Vitro: The Rationale to Co-Use PARP and ATM Inhibitors

  2021cites this paper
• Targeting nucleotide metabolism enhances the efficacy of anthracyclines and anti-metabolites in triple-negative breast cancer

  2021cites this paper
• MYCN recruits the nuclear exosome complex to RNA polymerase II to prevent transcription-replication conflicts.

  2021cites this paper
• Chk1 inhibitor-induced DNA damage increases BFL1 and decreases BIM but does not protect human cancer cell lines from Chk1 inhibitor-induced apoptosis.

  2021cites this paper
• Inhibition of triple‑negative breast cancer proliferation and motility by reactivating p53 and inhibiting overactivated Akt.

  2021cites this paper
• Class 1 Histone Deacetylases and Ataxia-Telangiectasia Mutated Kinase Control the Survival of Murine Pancreatic Cancer Cells upon dNTP Depletion

  2021influential citation
• Pseudorabies Virus Infection Triggers NF-κB Activation via the DNA Damage Response but Actively Inhibits NF-κB-Dependent Gene Expression

  2021cites this paper
• Radiotherapy as a tool to elicit clinically actionable signalling pathways in cancer

  2021cites this paper
• EZH2 inhibition sensitizes BRCA1-deficient breast cancer cells to synthetic lethal therapy with ATM inhibitors

  2021influential citation
• APOBEC3C, a nucleolar protein induced by genotoxins, is excluded from DNA damage sites

  2021cites this paper
• ATM phosphorylates PP2A subunit A resulting in nuclear export and spatiotemporal regulation of the DNA damage response

  2021influential citation
• Molecular basis of human ATM kinase inhibition

  2021cites this paper
• Sensors and Inhibitors for the Detection of Ataxia Telangiectasia Mutated (ATM) Protein Kinase.

  2021cites this paper
• Checkpoint Kinase 1 (Chk1) inhibition fails to activate the Stimulator of Interferon Genes (STING) innate immune signalling in a human coculture cancer system

  2021cites this paper
• MLK4 regulates DNA damage response and promotes triple-negative breast cancer chemoresistance

  2021cites this paper
• Exploiting DNA Damage Repair in Precision Cancer Therapy: BRCA1 as a Prime Therapeutic Target

  2021cites this paper
• Telomeric 8-oxo-guanine drives rapid premature senescence in the absence of telomere shortening

  2021cites this paper
• Protein kinase CK2: a potential therapeutic target for diverse human diseases

  2021cites this paper
• G2/M Checkpoint Abrogation With Selective Inhibitors Results in Increased Chromatid Breaks and Radiosensitization of 82-6 hTERT and RPE Human Cells

  2021cites this paper
• DNA Damage Repair Genes and Noncoding RNA in High-Grade Gliomas and Its Clinical Relevance

  2021cites this paper
• DNA damage repair in glioblastoma: current perspectives on its role in tumour progression, treatment resistance and PIKKing potential therapeutic targets

  2021cites this paper
• ATM Knockdown renders Glioma resistant to Temozolomide by Inhibiting IFIT1 Expression

  2021cites this paper
• Targeting nucleotide metabolism enhances the efficacy of anthracyclines and anti-metabolites in triple-negative breast cancer

  2021cites this paper
• Autophagic Organelles in DNA Damage Response

  2021cites this paper
• Silencing PEX26 as an unconventional mode to kill drug-resistant cancer cells and forestall drug resistance

  2021cites this paper
• ATM inhibitor KU‐55933 induces apoptosis and inhibits motility by blocking GLUT1‐mediated glucose uptake in aggressive cancer cells with sustained activation of Akt

  2021cites this paper